Sun Pharma’s $11.75 Billion Organon Bet Signals Aggressive Global Pharma Expansion Financing Shift
Source ↗
👁 7
💬 0
State Bank of India’s reported participation in global lending syndicates marks a key moment in India’s outbound acquisition financing landscape.
Sun Pharmaceutical Industries is structuring a massive acquisition of Organon & Co valued at about $11.75 billion, one of the largest overseas pharma deals by an Indian company. The transaction is designed to expand Sun’s footprint in women’s health, biosimilars and specialty medicines across more than 140 markets.
The deal is structured thr
Sun Pharmaceutical Industries is structuring a massive acquisition of Organon & Co valued at about $11.75 billion, one of the largest overseas pharma deals by an Indian company. The transaction is designed to expand Sun’s footprint in women’s health, biosimilars and specialty medicines across more than 140 markets.
The deal is structured thr
Comments (0)